MDT / USDT

ILV / USDC

ILV / USDT

DEXE / USDT

DASH / TRY

DASH / USDT

DASH / USDC

DASH / BTC

EUL / TRY

EUL / USDT

TAO / USD1

TAO / JPY

TAO / IDR

TAO / U

TNSR / USDC

TAO / BTC

TAO / TRY

TNSR / USDT

TAO / USDT

TAO / FDUSD

MOVING MEDIA ENTER LTD

BAWEJA STUDIOS LIMITED

D P WIRES LIMITED

INDIA TOUR. DEV. CO. LTD.

INFOBEANS TECHNO. LTD.

GLOTTIS LIMITED

ART NIRMAN LIMITED

HIND RECTIFIER LIMITED

THE NEW INDIA ASSU CO LTD

ATLAS CYCLE (HARYANA) LTD

R M DRIP & SPRINK SYS LTD

SUNREST LIFESCIENCE LTD

INVENTURE GRO & SEC LTD

SAMEERA AGRO AND INFRA L

MEDICAMEN ORGANICS LTD

AARTECH SOLONICS LIMITED

ALL E TECHNOLOGIES LTD

IDENTICAL BRAINS STUDIO L

INDIA VIX

CLASSIC ELECTRODE (IND) L

Click here to get full coverage on Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial - TipRanks

Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial  TipRanks

Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial - TipRanks

Click here to get full coverage on Suven Life Sciences Ltd Surges 12.45% to Day's High of Rs 197.95 — Outperforms Sector by 10.55 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 12.45% to Day's High of Rs 197.95 — Outperforms Sector by 10.55 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 12.45% to Day's High of Rs 197.95 — Outperforms Sector by 10.55 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Life Sciences' SUVN-I6107 Enters Phase 1—A Pipeline Deepener, Not a Valuation Spark - Bitget

Suven Life Sciences' SUVN-I6107 Enters Phase 1—A Pipeline Deepener, Not a Valuation Spark  Bitget

Suven Life Sciences' SUVN-I6107 Enters Phase 1—A Pipeline Deepener, Not a Valuation Spark - Bitget

Click here to get full coverage on Here's Why We're Watching Suven Life Sciences' (NSE:SUVEN) Cash Burn Situation - simplywall.st

Here's Why We're Watching Suven Life Sciences' (NSE:SUVEN) Cash Burn Situation  simplywall.st

Here's Why We're Watching Suven Life Sciences' (NSE:SUVEN) Cash Burn Situation - simplywall.st

Click here to get full coverage on SUVEN’s SUVN-I6107 Clears First-In-Human Hurdle: What Phase 1 Completion Means for Investors - TipRanks

SUVEN’s SUVN-I6107 Clears First-In-Human Hurdle: What Phase 1 Completion Means for Investors  TipRanks

SUVEN’s SUVN-I6107 Clears First-In-Human Hurdle: What Phase 1 Completion Means for Investors - TipRanks

Click here to get full coverage on Suven Life Sciences Clarifies Recent Price Movement Following Exchange Surveillance Queries - scanx.trade

Suven Life Sciences Clarifies Recent Price Movement Following Exchange Surveillance Queries  scanx.trade

Suven Life Sciences Clarifies Recent Price Movement Following Exchange Surveillance Queries - scanx.trade

Click here to get full coverage on Suven Life Sciences Eyes 2027 Breakthrough For Alzheimer’s Drug, Targets Multibillion-Dollar Opportunity - NDTV Profit

Suven Life Sciences Eyes 2027 Breakthrough For Alzheimer’s Drug, Targets Multibillion-Dollar Opportunity  NDTV Profit

Suven Life Sciences Eyes 2027 Breakthrough For Alzheimer’s Drug, Targets Multibillion-Dollar Opportunity - NDTV Profit

Click here to get full coverage on Suven-Cohance merger done - Speciality Chemicals Magazine

Suven-Cohance merger done  Speciality Chemicals Magazine

Suven-Cohance merger done - Speciality Chemicals Magazine

Click here to get full coverage on Staten Island physicians honored for excellence in emergency medicine, radiology - SILive.com

Staten Island physicians honored for excellence in emergency medicine, radiology  SILive.com

Staten Island physicians honored for excellence in emergency medicine, radiology - SILive.com

Click here to get full coverage on Suven Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of... - Medical Dialogues

Suven Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of...  Medical Dialogues

Suven Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of... - Medical Dialogues

Click here to get full coverage on Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1 - NeurologyLive

Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1  NeurologyLive

Phase 2 Study to Test Therapeutic Potential of Samelisant for Narcolepsy Type 1 - NeurologyLive

Click here to get full coverage on BNP Paribas buys over Rs 54 crore worth shares in Capri Global Capital from Morgan Stanley - TradingView

BNP Paribas buys over Rs 54 crore worth shares in Capri Global Capital from Morgan Stanley  TradingView

BNP Paribas buys over Rs 54 crore worth shares in Capri Global Capital from Morgan Stanley - TradingView

Click here to get full coverage on Suven Life Sciences Ltd is Rated Strong Sell - Markets Mojo

Suven Life Sciences Ltd is Rated Strong Sell  Markets Mojo

Suven Life Sciences Ltd is Rated Strong Sell - Markets Mojo

Click here to get full coverage on Suven Life Sciences Submits Q4FY26 Compliance Certificate Under SEBI Regulation 74(5) - scanx.trade

Suven Life Sciences Submits Q4FY26 Compliance Certificate Under SEBI Regulation 74(5)  scanx.trade

Suven Life Sciences Submits Q4FY26 Compliance Certificate Under SEBI Regulation 74(5) - scanx.trade

Click here to get full coverage on Suven Life Sciences Ltd Surges 7.16% to Day's High of Rs 182.2 — Outperforms Sector by 7.26 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 7.16% to Day's High of Rs 182.2 — Outperforms Sector by 7.26 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 7.16% to Day's High of Rs 182.2 — Outperforms Sector by 7.26 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo

Suven Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals  Markets Mojo

Suven Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo

Click here to get full coverage on Suven Life Sciences Ltd Surges 7.34% to Day's High of Rs 171.2 — Outperforms Sector by 7.52 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 7.34% to Day's High of Rs 171.2 — Outperforms Sector by 7.52 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 7.34% to Day's High of Rs 171.2 — Outperforms Sector by 7.52 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Life Sciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals - Markets Mojo

Suven Life Sciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals  Markets Mojo

Suven Life Sciences Ltd Faces Bearish Momentum Amid Mixed Technical Signals - Markets Mojo

Click here to get full coverage on Suven Life Sciences Reports Widened Q3 Consolidated Net Loss of ₹1.02 Billion - scanx.trade

Suven Life Sciences Reports Widened Q3 Consolidated Net Loss of ₹1.02 Billion  scanx.trade

Suven Life Sciences Reports Widened Q3 Consolidated Net Loss of ₹1.02 Billion - scanx.trade

Click here to get full coverage on Suven Life Sciences Ltd Surges 7.25% to Day's High of Rs 159 — Outperforms Sector by 9.45 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 7.25% to Day's High of Rs 159 — Outperforms Sector by 9.45 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 7.25% to Day's High of Rs 159 — Outperforms Sector by 9.45 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Life Sciences completes Phase-2b patient enrolment for MDD drug trial ahead of schedule - BusinessLine

Suven Life Sciences completes Phase-2b patient enrolment for MDD drug trial ahead of schedule  BusinessLine

Suven Life Sciences completes Phase-2b patient enrolment for MDD drug trial ahead of schedule - BusinessLine

Click here to get full coverage on Suven Life Sciences Ltd Surges 7.79% to Day's High of Rs 144.7 — Outperforms Sector by 5.72 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 7.79% to Day's High of Rs 144.7 — Outperforms Sector by 5.72 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 7.79% to Day's High of Rs 144.7 — Outperforms Sector by 5.72 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Pharmaceuticals - 11 stocks that Goldman Sachs says buy on high earnings growth and reasonable valuations - The Economic Times

Suven Pharmaceuticals - 11 stocks that Goldman Sachs says buy on high earnings growth and reasonable valuations  The Economic Times

Suven Pharmaceuticals - 11 stocks that Goldman Sachs says buy on high earnings growth and reasonable valuations - The Economic Times

Click here to get full coverage on Suven Life Sciences Ltd Surges 7.88% to Day's High of Rs 141 — Outperforms Sector by 8.06 Percentage Points - Markets Mojo

Suven Life Sciences Ltd Surges 7.88% to Day's High of Rs 141 — Outperforms Sector by 8.06 Percentage Points  Markets Mojo

Suven Life Sciences Ltd Surges 7.88% to Day's High of Rs 141 — Outperforms Sector by 8.06 Percentage Points - Markets Mojo

Click here to get full coverage on Suven Life Sciences Allots 44.77 Lakh Equity Shares, Announces Leadership Changes - scanx.trade

Suven Life Sciences Allots 44.77 Lakh Equity Shares, Announces Leadership Changes  scanx.trade

Suven Life Sciences Allots 44.77 Lakh Equity Shares, Announces Leadership Changes - scanx.trade

Click here to get full coverage on Suven Life Sciences Ltd Hits Intraday High with 10.45% Surge on 4 Feb 2026 - Markets Mojo

Suven Life Sciences Ltd Hits Intraday High with 10.45% Surge on 4 Feb 2026  Markets Mojo

Suven Life Sciences Ltd Hits Intraday High with 10.45% Surge on 4 Feb 2026 - Markets Mojo

Click here to get full coverage on Suven Life Sciences Reports Wider Quarterly Loss of Rs 77.3 Crore - scanx.trade

Suven Life Sciences Reports Wider Quarterly Loss of Rs 77.3 Crore  scanx.trade

Suven Life Sciences Reports Wider Quarterly Loss of Rs 77.3 Crore - scanx.trade

Click here to get full coverage on Suven Pharmaceuticals is now Cohance Lifesciences - Indian Pharma Post

Suven Pharmaceuticals is now Cohance Lifesciences  Indian Pharma Post

Suven Pharmaceuticals is now Cohance Lifesciences - Indian Pharma Post

Click here to get full coverage on Suven Life Sciences Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results - scanx.trade

Suven Life Sciences Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results  scanx.trade

Suven Life Sciences Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results - scanx.trade

Click here to get full coverage on ₹120 to ₹238: This small-cap pharma stock zooms nearly 100% in just 22 sessions. Are you holding it? - Mint

₹120 to ₹238: This small-cap pharma stock zooms nearly 100% in just 22 sessions. Are you holding it?  Mint

₹120 to ₹238: This small-cap pharma stock zooms nearly 100% in just 22 sessions. Are you holding it? - Mint

Click here to get full coverage on Suven Life Sciences Board Approves ₹425.70 Crore Warrant Conversion - scanx.trade

Suven Life Sciences Board Approves ₹425.70 Crore Warrant Conversion  scanx.trade

Suven Life Sciences Board Approves ₹425.70 Crore Warrant Conversion - scanx.trade

Click here to get full coverage on Promoters exchange 1% shares in Edelweiss Financial; Radiant Global Fund buys 1% stake in Ashish Kacholia-backed Dudigital Global - TradingView

Promoters exchange 1% shares in Edelweiss Financial; Radiant Global Fund buys 1% stake in Ashish Kacholia-backed Dudigital Global  TradingView

Promoters exchange 1% shares in Edelweiss Financial; Radiant Global Fund buys 1% stake in Ashish Kacholia-backed Dudigital Global - TradingView

Click here to get full coverage on Suven Life Sciences Ltd Hits Intraday High with 7.3% Surge on 1 Feb 2026 - Markets Mojo

Suven Life Sciences Ltd Hits Intraday High with 7.3% Surge on 1 Feb 2026  Markets Mojo

Suven Life Sciences Ltd Hits Intraday High with 7.3% Surge on 1 Feb 2026 - Markets Mojo

Click here to get full coverage on Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family - Advent International

Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family  Advent International

Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family - Advent International

Click here to get full coverage on Suven Life Sciences Issues Clarification on Recent Price Movement to BSE - scanx.trade

Suven Life Sciences Issues Clarification on Recent Price Movement to BSE  scanx.trade

Suven Life Sciences Issues Clarification on Recent Price Movement to BSE - scanx.trade

Click here to get full coverage on Suven Life Sciences Achieves All-Time High Amid Strong Performance Trends - Markets Mojo

Suven Life Sciences Achieves All-Time High Amid Strong Performance Trends  Markets Mojo

Suven Life Sciences Achieves All-Time High Amid Strong Performance Trends - Markets Mojo

Click here to get full coverage on Suven Life Sciences Achieves 100% Patient Enrollment for Phase-2B Ropanicant Trial - scanx.trade

Suven Life Sciences Achieves 100% Patient Enrollment for Phase-2B Ropanicant Trial  scanx.trade

Suven Life Sciences Achieves 100% Patient Enrollment for Phase-2B Ropanicant Trial - scanx.trade

Click here to get full coverage on Why Suven Life Sciences Share Price is Rising - Equitymaster

Why Suven Life Sciences Share Price is Rising  Equitymaster

Why Suven Life Sciences Share Price is Rising - Equitymaster

Click here to get full coverage on Suven Life Sciences - Sunil Singhania’s Abakkus Portfolio: 7 stocks gain up to 60% in FY26; 2 new buys in Q3 - The Economic Times

Suven Life Sciences - Sunil Singhania’s Abakkus Portfolio: 7 stocks gain up to 60% in FY26; 2 new buys in Q3  The Economic Times

Suven Life Sciences - Sunil Singhania’s Abakkus Portfolio: 7 stocks gain up to 60% in FY26; 2 new buys in Q3 - The Economic Times

Click here to get full coverage on Suven Pharmaceuticals rebrands as Cohance Lifesciences - bestmediainfo.com

Suven Pharmaceuticals rebrands as Cohance Lifesciences  bestmediainfo.com

Suven Pharmaceuticals rebrands as Cohance Lifesciences - bestmediainfo.com

Click here to get full coverage on Suven doses first subjects in trial of SUVN-I6107 for cognitive disorders - Clinical Trials Arena

Suven doses first subjects in trial of SUVN-I6107 for cognitive disorders  Clinical Trials Arena

Suven doses first subjects in trial of SUVN-I6107 for cognitive disorders - Clinical Trials Arena

Click here to get full coverage on 5 top performing pharma stock in last year: Wockhardt, Suven Life Sciences, Blue Jet Healthcare,... - Moneycontrol.com

5 top performing pharma stock in last year: Wockhardt, Suven Life Sciences, Blue Jet Healthcare,...  Moneycontrol.com

5 top performing pharma stock in last year: Wockhardt, Suven Life Sciences, Blue Jet Healthcare,... - Moneycontrol.com

Click here to get full coverage on Suven Life Sciences Ltd: Technical Momentum Shifts Amid Bearish Sentiment - Markets Mojo

Suven Life Sciences Ltd: Technical Momentum Shifts Amid Bearish Sentiment  Markets Mojo

Suven Life Sciences Ltd: Technical Momentum Shifts Amid Bearish Sentiment - Markets Mojo

Click here to get full coverage on First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences - Medical Dialogues

First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences  Medical Dialogues

First patient randomized in Ropanicant Phase 2b trial for Major Depressive Disorder: Suven Life Sciences - Medical Dialogues

Click here to get full coverage on Suven Life Sciences Ltd Sees Mixed Technical Signals Amid Price Momentum Shift - Markets Mojo

Suven Life Sciences Ltd Sees Mixed Technical Signals Amid Price Momentum Shift  Markets Mojo

Suven Life Sciences Ltd Sees Mixed Technical Signals Amid Price Momentum Shift - Markets Mojo

Click here to get full coverage on Suven Life Sciences Advances Alzheimer's Drug Trial, Completes ₹857 Crore Fundraising - scanx.trade

Suven Life Sciences Advances Alzheimer's Drug Trial, Completes ₹857 Crore Fundraising  scanx.trade

Suven Life Sciences Advances Alzheimer's Drug Trial, Completes ₹857 Crore Fundraising - scanx.trade

Click here to get full coverage on Suven to Divi’s: Indian CDMOs seize opportunity in pivot away from China amid global trade tensions - Moneycontrol.com

Suven to Divi’s: Indian CDMOs seize opportunity in pivot away from China amid global trade tensions  Moneycontrol.com

Suven to Divi’s: Indian CDMOs seize opportunity in pivot away from China amid global trade tensions - Moneycontrol.com

Click here to get full coverage on Suven Life Sciences Q2 FY26: Mounting Losses Signal Deepening Crisis as Revenue Struggles Continue - Markets Mojo

Suven Life Sciences Q2 FY26: Mounting Losses Signal Deepening Crisis as Revenue Struggles Continue  Markets Mojo

Suven Life Sciences Q2 FY26: Mounting Losses Signal Deepening Crisis as Revenue Struggles Continue - Markets Mojo

Click here to get full coverage on Sunil Singhania, Prashant Jain invest in Suven Life preferential issue; stock jumps 12% - CNBC TV18

Sunil Singhania, Prashant Jain invest in Suven Life preferential issue; stock jumps 12%  CNBC TV18

Sunil Singhania, Prashant Jain invest in Suven Life preferential issue; stock jumps 12% - CNBC TV18

Click here to get full coverage on Advent-owned Indian CDMOs Suven Pharma, Cohance Lifesciences plan merger - Fierce Pharma

Advent-owned Indian CDMOs Suven Pharma, Cohance Lifesciences plan merger  Fierce Pharma

Advent-owned Indian CDMOs Suven Pharma, Cohance Lifesciences plan merger - Fierce Pharma

Click here to get full coverage on Suven Life Sciences Q3 FY26: Mounting Losses Signal Deep Operational Crisis - Markets Mojo

Suven Life Sciences Q3 FY26: Mounting Losses Signal Deep Operational Crisis  Markets Mojo

Suven Life Sciences Q3 FY26: Mounting Losses Signal Deep Operational Crisis - Markets Mojo

Click here to get full coverage on Suven Life Sciences Achieves 52-Week High Amid Broader Market Downturn - Markets Mojo

Suven Life Sciences Achieves 52-Week High Amid Broader Market Downturn  Markets Mojo

Suven Life Sciences Achieves 52-Week High Amid Broader Market Downturn - Markets Mojo

Click here to get full coverage on Suven Pharmaceuticals Executes Rs. 76.37 Crore Block Trade on NSE - scanx.trade

Suven Pharmaceuticals Executes Rs. 76.37 Crore Block Trade on NSE  scanx.trade

Suven Pharmaceuticals Executes Rs. 76.37 Crore Block Trade on NSE - scanx.trade

Click here to get full coverage on Tech Query: HDFC Bank, Eternal (Zomato), Dixon Technologies, Cohance Lifesciences (Suven Pharmaceuticals) - What Is The Outlook? Where Are These Stocks Headed? - BusinessLine

Tech Query: HDFC Bank, Eternal (Zomato), Dixon Technologies, Cohance Lifesciences (Suven Pharmaceuticals) - What Is The Outlook? Where Are These Stocks Headed?  BusinessLine

Tech Query: HDFC Bank, Eternal (Zomato), Dixon Technologies, Cohance Lifesciences (Suven Pharmaceuticals) - What Is The Outlook? Where Are These Stocks Headed? - BusinessLine

SUVEN

Price Chart

Key Statistics

Technicals

About SUVEN

Latest News

Suven Life Sciences Nears Key Data Milestone in Phase 2b Depression Drug Trial - TipRanks

Suven Life Sciences Ltd Surges 12.45% to Day's High of Rs 197.95 — Outperforms Sector by 10.55 Percentage Points - Markets Mojo

Suven Life Sciences' SUVN-I6107 Enters Phase 1—A Pipeline Deepener, Not a Valuation Spark - Bitget

Advanced Charts

Top Gainers

Top Losers